Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Teduglutide in Chinese Adults With Short Bowel Syndrome Dependent on Parenteral Support
NCT06973304Phase 3Active, not recruiting
- Sponsor
- Takeda
- Start
- Jun 2025
- Primary completion
- Feb 2027
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of teduglutide in short bowel syndrome (SBS), sponsored by Takeda. Started Jun 2025; status: active, not recruiting.
02
Drugs
teduglutide
03
Conditions
short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT06973304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06973304.